logo
15:58 Dec 12

Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
193.86
+1.96 (+1.02%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Marksans Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
193.86
+1.96 (+1.02%)
15:58 Dec 12
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

42/100
Technically Neutral

Strength

6

Weakness

3

Opportunity

0

Threats

0

15.42 %

ROE %

11.74 %

ROA %

7.76

EPS

54.44

BVPS

14.51 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1490.84 1852.14 2177.41 2622.84 2730.71
Operating Expenses +
1231.95 1512.82 1718.83 2094.2 2221.55
Raw Material
703.92 927.75 1111.98 1327.5 1348.35
Increase Decrease in Cost
12.9 -6.39 -73.86 -183.76 -154.39
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
220.3 239.37 293.64 350.3 387.84
Miscellaneous Expenses
621.33 981.65 1275.63 1749.12 639.75
Operating Profit
258.89 339.32 458.58 528.64 509.16
Other Income
41.85 59.31 50.42 70.38 71.58
Depreciation
44.78 51.85 74.27 83.39 93.45
Interest
8.45 9.13 11.2 11.66 17.99
Profit before tax and exceptio..
247.51 337.65 423.53 503.97 469.3
Exceptional Items
0 0 0 0 0
PBT
247.51 337.65 423.53 503.97 469.3
Provision for Taxation
60.7 72.33 108.63 121.35 116.16
Net Profit
186.81 265.32 314.9 382.62 353.14
NET Profit after MI
186.81 266.31 313.7 380.58 351.68
EPS
4.51 6.41 6.92 8.4 7.77
Operating Profit Margin (%)
17.37 18.32 21.06 20.16 18.65
Net Profit Margin (%)
12.53 14.38 14.41 14.51 12.88

Marksans Pharma Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: